Summary

  • Accelevation’s 9 October agreement provides $650 million of facilities, but only $400 million was borrowed at closing: $250 million of term debt and $150 million of revolver debt.
  • The closing borrowings, together with cash, repaid the former credit agreement and paid transaction expenses. The filing does not say that $650 million—or even the $400 million draw—was newly allocated to construction or expansion.
  • The remaining nominal $250 million of revolver capacity carries an unused-line fee and sits behind collateral and financial covenants. Its value depends on later draw decisions and the company’s ability to turn orders into cash.

Capacity and cash are different balance-sheet facts

A credit announcement can make an available limit look like capital already in hand. Accelevation’s new agreement is a useful case in why the distinction matters. The senior-secured package totals $650 million, split between a $250 million term loan and a $400 million revolving facility. At the 9 October closing, the term loan was fully drawn and $150 million was drawn on the revolver. Total principal under the new facilities was therefore $400 million, or about 61.5% of commitments. Before any letters of credit or swingline use, $250 million remained undrawn.

That arithmetic is the start of the story, not a use-of-funds statement. The 8-K says the closing proceeds, together with cash on hand, repaid all outstanding obligations under the previous credit agreement and paid transaction expenses. It does not divide the $400 million between those uses. It also does not say that the undrawn balance was committed to a data-centre project, inventory build or acquisition. The issuer’s language about flexibility for growth describes what the agreement may permit; it is not evidence that new growth cash entered the company.

The distinction matters because the public release’s $650 million number mixes three different things: a term loan already borrowed, a partly used revolver, and revolving capacity still available subject to contract terms. At close, the revolving commitment was $400 million, but $150 million had already been borrowed. The agreement also sets sublimits of $100 million for letters of credit and $40 million for swingline loans. Those are not additional facilities. They can occupy part of the same revolving framework, so nominal undrawn capacity is not automatically the same as cash that could be drawn at any moment.

A cheaper margin has a timetable

The price headline also needs a calendar. Accelevation’s 13 October release compares the prior facilities’ SOFR margins of 4.50%–5.25% with a 1.50%–2.50% range for the new package. That is a meaningful repricing signal. The filed agreement, however, sets an initial Term SOFR margin of 2.25% until the company delivers the compliance certificate for the fiscal quarter ending 30 June 2027. Only after that certificate does the leverage-based 1.50%–2.50% grid apply. Base-rate loans begin at a 1.25% margin and later move to a separate 0.50%–1.50% grid.

That distinction is not semantic. The margin is added to the benchmark rate; it is not the all-in borrowing rate. The amount actually paid also depends on the benchmark, average principal outstanding, loan type, fees and timing. A simple sensitivity helps show the scale without claiming savings: at a constant $400 million balance, every 100 basis points of margin is $4 million a year. The agreement does not establish that the balance will stay at $400 million for a full year, nor does the comparison isolate what the company would otherwise have paid after its IPO debt repayment. The $4 million is a ruler, not a forecast.

The unused revolver is not costless either. Until the compliance certificate for the quarter ending 30 June 2027, the company pays a 0.300% annual commitment fee on unused revolving commitments. Later that fee ranges from 0.200% to 0.350% based on leverage. If the full nominal $250 million remainder stayed unused for an entire year, with no letters of credit or swingline usage, 0.300% would equal $750,000. Actual fees depend on usage and the later pricing tier. The fee buys an option to borrow; it should not be counted as cash spent on operations or dismissed as free liquidity.

The term loan has a different clock. It amortizes by $3.125 million each quarter beginning with the quarter ending 31 March 2027, a scheduled 5% of original principal per year. The remaining principal is due at the 9 October 2031 maturity. The revolving facility has no scheduled amortization, but it remains subject to renewal, repayment and covenant constraints. A five-year maturity gives management time to deploy capital; it does not remove the repayment obligation.

The refinancing sits between two dated snapshots

The old-debt comparison is especially vulnerable to false precision. Accelevation’s 1 October prospectus reported approximately $651.5 million of term borrowings and no revolver borrowings at 30 June 2026, with an 8.772% weighted-average interest rate on that date. It also estimated $170.6 million of net IPO proceeds for repayment of old-credit-agreement borrowings. The new agreement was entered into on 9 October. Those are three dates in a sequence, not a same-day before-and-after balance sheet.

It would be tempting to subtract the new $400 million draw from the June $651.5 million balance and call the difference deleveraging. That would ignore the IPO repayment in between, cash on hand, fees and changes in balances. The 8-K only confirms that the old facility was repaid in full at closing of the new one. It does not provide a full same-date bridge from June to October. A careful reading can say the company transitioned to a lower-spread syndicated facility and replaced the earlier agreement; it cannot claim that the difference between those two snapshots equals debt reduction or annual interest savings.

The new commitment was arranged with Bank of America as administrative and collateral agent, alongside Bank of America, JPMorgan Chase, Morgan Stanley, KeyBank and PNC as lead arrangers. This broader bank group and the lower disclosed spread indicate a changed financing relationship after the public listing. But a lower margin alone does not prove a lower total cost of capital: the loan is secured, unused capacity has a fee, there is amortization, and the agreement contains restrictions on debt, liens, asset sales, investments, restricted payments, junior-debt prepayments and affiliate transactions.

Growth still has to convert orders into cash

Accelevation operates in the market for electrical distribution and other factory-built systems used in data centres. Its prospectus reported 147% year-over-year revenue growth in 2025 and a $1.111 billion backlog at 30 June 2026. Those figures help explain why management wants room to invest. They do not guarantee that orders will be delivered on schedule or collected at attractive margins. The filing says backlog can be delayed, adjusted or cancelled, including at a customer’s convenience without a significant cancellation penalty.

Customer concentration makes the distinction more consequential. Two customers represented approximately 61.2% of direct revenue in 2025. If either customer slows a project or changes its delivery schedule, working capital and equipment commitments may arrive before corresponding cash. The agreement’s revolver could bridge that timing gap. The same debt could also magnify a cash shortfall if a delayed project leaves the borrower servicing interest and fees while inventory or installed equipment waits for acceptance.

The prospectus reported company-defined Adjusted EBITDA of $90.867 million for 2025 and $68.371 million for the first half of 2026. Company-defined Free Cash Flow was negative $16.385 million in 2025 and negative $15.777 million in the first half of 2026. These are non-GAAP measures, not interchangeable with cash available for debt service. Adjusted EBITDA includes specified add-backs; Free Cash Flow deducts capital expenditure from operating cash flow. Together, the figures say the business was growing and generating adjusted earnings while still consuming cash after investment.

That is exactly the setting in which a revolver can be valuable, but also the setting in which the actual draw, cash conversion and covenant headroom matter more than the facility headline.

Sources